Species Identity &
Genomic Confirmation
Species confirmed as Ganoderma sichuanense Zhao & Zhang (= G. lingzhi) by independent genomic sequencing
Inqaba Biotechnical Industries (Pty) Ltd conducted dual-marker ITS and EF1-alpha sequencing of the MG-LZ8™ source culture. ITS region: 99.69% identity match. EF1-alpha region: 100% identity match. GenBank accession numbers OR685549.1 (ITS) and JX029974.1 (EF1-alpha) provide independently verifiable links to deposited reference sequences at NCBI.
| Marker | Identity Match | GenBank Accession | Species Confirmed |
|---|---|---|---|
| ITS Region | 99.69% | OR685549.1 | G. sichuanense (= G. lingzhi) |
| EF1-alpha Region | 100% | JX029974.1 | G. sichuanense (= G. lingzhi) |
The same analysis confirmed a commercially available product from a high-profile international mycology supplier as Ganoderma sessile — a taxonomically distinct North American species — misidentified as G. lucidum in that product's labelling.
Pre-Clinical
Immunological Validation
Measurable innate and adaptive immune response in mice, with no effect on cancer cell growth
Prof. Vaclav Větvička, Department of Pathology, University of Louisville, Kentucky USA — one of the world's leading researchers in beta-glucan immunology — conducted an independent, commissioned pre-clinical study of MG-LZ8™ in 2018.
Mice received a single 100 μg dose. At 24 hours, IL-2 production increased from 1.1 pg/ml to 262.4 pg/ml (238-fold), and phagocytosing neutrophils (the first-responder immune cells) increased from 31.1% baseline to 47.2% (+51.7%). In cell culture at 48 hours, the extract showed no significant effect on the growth of four cancer cell lines (MCF-7, HL-60, NCI-H23, PC-3) at any dose tested.
Compound Profile &
Comparative Analysis
Antler extract 14:1 MG-LZ8™ compared to the world's 16:1 benchmark conk extract: a very similar triterpenoid profile, from antler tissue.
A direct comparative LC-MS/QTOF analysis was conducted at the Central Analytical Facility (CAF), Stellenbosch University — instrument operator Prof. Marietjie Stander; report compiled by Dr. T. Little, Raluka Biotech — placing MG-LZ8™ alongside the 16:1 conk extract under identical analytical conditions.
The report concluded that both extracts were “abundant in triterpenoids, showing a very similar profile with only marginal variances in the ratios between compounds”, with ganoderic acids A and B the most abundant in both. Percentages below are relative proportions of the most abundant compounds in each sample, not concentrations. Compound identities are provisional pending full MS/MS fragmentation.
| Compound | Conk Benchmark 16:1 (%) | MG-LZ8™ (%) | Differential |
|---|---|---|---|
| Ganoderic Acid A (GA) | 17.73 | 16.13 | — |
| Ganoderic Acid B (GB) | 7.00 | 8.40 | MG-LZ8™ +20% |
| Ganoderic Acid D (GD) | 11.00 | 8.68 | — |
| 12-Acetoxyganoderic Acid F | 8.81 | 6.97 | — |
| Ganoderenic Acid B (GEB) | 9.75 | 5.29 | — |
| DHTLO | 5.66 | 7.05 | MG-LZ8™ +25% |
| Ganoderic Acid C2 (GC2) | 4.97 | 6.03 | MG-LZ8™ +21% |
| GA/B (RT 32.17) | 0.14 | 8.07 | Higher in MG-LZ8™ (comparator near detection limit) |
| Unknown (RT 28.5) | 3.91 | 5.51 | MG-LZ8™ +41% |
| Unknown (RT 25.84) | Not detected | 3.07 | MG-LZ8™ only |
MG-LZ8™ full triterpenoid spectrum vs two detectable peaks in registered SA pharmaceutical Reishi product
A separate LC-MS/QTOF analysis compared MG-LZ8™ against a commercially available Reishi product from a registered South African pharmaceutical supplier. MG-LZ8™ produced a rich, well-resolved chromatographic profile with 11 specific triterpenoid compounds identified. The comparator product produced two detectable peaks.
β-Glucan
Quantification
β-glucan confirmed at 9.10% w/w (low heat extract) in MG-LZ8™ finished extract by Megazyme K-YBGL assay
The Neogen/Megazyme K-YBGL assay was applied to MG-LZ8™ finished extract (sample H23-25401). At 9.10% beta-glucan in a 15mg capsule, MG-LZ8™ delivers 1.37mg beta-glucan per dose. The same run confirmed the 16:1 conk extract at 20.31% beta-glucan (which confirms a high-heat process). The 9.10% figure represents the finished extract from a low heat/cold-boil extraction. A second Megazyme run will be conducted to complete the full glucan profile; the current result reflects a dual stage extraction. A third high-heat extraction will be added to the process, and Prof Marietjie Stander will test the new improved extract... named; "FS-19"
Purity, Safety
& Heavy Metals
Starch below detection limit. Glucose the only sugar present.
SANAS-accredited laboratory Mérieux NutriSciences (accreditation T0350) conducted a full purity and safety analysis of MG-LZ8™ in October 2023.
| Parameter | Result | Limit / Significance |
|---|---|---|
| Starch | <0.50g/100g (below detection) | Confirms zero grain substrate contamination |
| Total fat | 25.6g/100g | Consistent with a retained lipid-soluble fraction |
| Glycaemic carbohydrates | 2.71g/100g (glucose only) | Confirms absence of starch-derived carbohydrate load |
Heavy metals confirmed well below international limits at raw material stage
| Heavy Metal | Result | International Limit | Margin |
|---|---|---|---|
| Lead | 0.171 ppm | <3.0 ppm | 17.5× below limit |
| Cadmium | 0.018 ppm | <1.0 ppm | 55× below limit |
| Mercury | 0.002 ppm | <0.10 ppm | 50× below limit |
Extraction Methodology
& Consistency
29× extraction multiplier confirmed by independent HPLC. 12× antler morphology advantage confirmed by expert chromatographic interpretation.
Verve Dynamics Laboratory (R.P. Davies, Somerset West) conducted independent HPLC comparative analysis in July 2017. The ethanolic only extract showed a 29-fold increase in total triterpenoid content compared to raw antler material. The polar extraction ratio is still to be measured. Expert chromatographic interpretation of the antler vs standard conk comparison identified approximately a 12-fold triterpenoid concentration advantage for the antler form.
Combined cascade: 12 × 29 = 348×
One 15mg capsule of MG-LZ8™ delivers the active compound equivalent of approximately 5,220mg of standard imported Reishi powder.
The 12× and 29× are independent, compounding advantages: 12× is a powder-to-powder morphological comparison (Antler vs conk); 29× is the extraction multiplier applied to that superior starting material.
In-house extraction profile confirmed identical to original Verve Dynamics validated baseline
Following technology transfer and in-house extraction implementation, Ecogreen Analytics (Gregory Ondrejkovic) independently verified that the current MG-LZ8™ in-house extraction profile matches the original Verve Dynamics validated profile. This confirms that the 348× concentration cascade is maintained across production batches under in-house conditions.
Independent Academic Validation
of Cultivation Methodology
Mushroom Guru antler cultivation protocol independently reproduced and confirmed under academic supervision at University of the Free State
Miss. C. Van der Berg, under the supervision of Prof. B.C. Viljoen (Department of Microbial, Biochemical and Food Biotechnology, University of the Free State), and Mushroom Guru, conducted a formal academic study of Ganoderma lucidum industrial and medicinal applications. A Mushroom Guru G. lucidum tissue culture (UFS-GL1) was used as the founding culture.
The Mushroom Guru elevated CO₂ antler induction protocol was independently reproduced under controlled academic conditions. Antler formation was confirmed within 28 days.
Mr C. Fourie (2015) — Craig Fourie’s prior research on lignocellulosic substrate conversion via Ganoderma mycelium — is cited as primary academic literature within the thesis. This constitutes formal academic citation of Mushroom Guru’s founder as an independent scientific source.
Laboratory
Verification Summary
| Laboratory | Key Finding | Date |
|---|---|---|
| Verve Dynamics (R.P. Davies) Somerset West, South Africa | 12× antler morphology triterpenoid advantage confirmed. 29× extraction cascade confirmed by HPLC. Dual-phase CoAs issued with full heavy metals and microbiological panels. | July 2017 |
| Stellenbosch University CAF Prof. Marietjie Stander (instrument operator); Dr. T. Little, Raluka Biotech (report compiler) | 11 specific triterpenoid compounds identified. Side by side with the global 16:1 conk benchmark: a very similar triterpenoid profile, with ganoderic acids A and B most abundant in both. Comparator pharmaceutical product: two detectable peaks. | May & Oct 2021 |
| Mérieux NutriSciences SANAS-accredited T0350 | Starch below detection limit. Glucose the only sugar detected. Full nutritional profile, including fat, protein, fibre and fatty acids. | Oct 2023 |
| Neogen / Megazyme K-YBGL | β-glucan confirmed at 9.10% w/w (cold-boil extract) using industry-standard K-YBGL method. Same run confirmed conk benchmark at 20.31% and returned 97% total glucan (67.7% beta, 29.7% alpha) for a South African comparator “extract” — a profile no mushroom extract can produce, indicating added non-mushroom glucan. | Oct 2023 |
| Inqaba Biotechnical Industries Pretoria, South Africa | Species identity confirmed as G. sichuanense Zhao & Zhang (= G. lingzhi). ITS: 99.69%. EF1-alpha: 100%. GenBank accessions OR685549.1 and JX029974.1 provide independently verifiable reference links at NCBI. Dual-marker confirmation places the MG-LZ8™ source culture within the most phylogenetically ancient lineage of G. lingzhi — a finding with direct relevance to compound profile and clinical positioning. | Aug 2025 |
| Ecogreen Analytics Gregory Ondrejkovic | In-house extraction confirmed matching the original Verve Dynamics validated profile. Extraction consistency maintained across multiple production batches, confirming successful technology transfer to the Mushroom Guru GMP-audited facility in Strand. | Feb 2025 |
The Antler
Developmental Biology
The antler is not a stress response — it is the mushroom’s natural exploration state, activated by a single environmental signal
Ganoderma sichuanense carries two fully encoded developmental programs in its genome. Which one runs is determined by a single environmental signal: the ratio of CO₂ to oxygen in the immediate atmosphere.
When CO₂ is elevated — as it is underground, inside decaying wood, or in a sealed cultivation environment — the organism activates its exploration program. In the most recent transcriptomic study of elevated CO₂, 5,913 genes changed expression across the study, with almost 3,000 changing in a single fruiting-body comparison (Fang et al., 2026). It grows vertically, elongating and sending structures upward to find oxygen. The reproductive program is held in reserve.
The moment oxygen is detected as the growing tip reaches open air, the signal reverses. The antler program is downregulated. The pileus begins to form, spore production begins, and the organism transitions from exploration to reproduction. The genome study of G. lucidum found triterpenoid content highest at the primordium stage, falling as the mature fruiting body forms (Chen et al., 2012).
Elevated CO₂ signal active. Organism growing vertically toward oxygen. Full secondary metabolite biosynthesis running. Triterpenoid content at its developmental peak (Chen et al., 2012). Reproductive switch held in reserve.
Oxygen signal received. Antler program downregulated. Pileus formation begins. Biological resources redirected from secondary metabolite production to spore production and reproduction. Triterpenoid density falls.
Mushroom Guru harvests exclusively at the antler stage — before the oxygen signal reverses the developmental program.
Glyconutrient Profile —
The Communication Layer
MG-LZ8™ contains five of the eight essential saccharides required for immune cell communication — confirmed by independent MS/QTOF and nutritional analysis
Research by Dr. Steve Nugent identified eight monosaccharides required for the glycoprotein structures on cell surfaces that govern immune cell-to-cell communication. Modern diets typically provide only two of these eight.
Mannose and fucose are of particular immunological significance. Mannose engages the mannose receptor CD206 on macrophages and dendritic cells. Fucose is a key component of the selectin-ligand structures that govern immune cell migration and tissue homing.
The LZ-8 immunomodulatory protein — the first mushroom immune protein ever characterised, isolated from Ganoderma — has a structure with functional homology to the Fc domain of human immunoglobulins.
Clinical Translation —
What the Data Means in Practice
Laboratory numbers translated into clinical and formulation relevance
| Laboratory Finding | Clinical / Formulation Relevance |
|---|---|
| IL-2 238-fold increase at 24 hours (Větvička, 2018) | IL-2 is the primary cytokine governing T-cell proliferation and immune surveillance. A 238-fold increase in mice signals strong adaptive immune signalling. Human studies have not yet been done; practitioners should treat this as pre-clinical evidence. |
| Phagocytosing neutrophils +51.7% at 24 hours | Neutrophils are the first-responder cell population. A +51.7% increase at 24 hours in mice indicates a more active innate response. Human studies have not yet been done. |
| No significant effect on four cancer cell lines at any dose | The extract neither stimulated nor inhibited cancer cell growth in culture. This is a cell-culture finding only; healthy-cell and human safety were not tested in this study. |
| Starch below detection limit. | For formulators: clean label calculations, no hidden carbohydrate load. For practitioners: suitable for low-carbohydrate or grain-free protocols. |
| 15mg dose — 348× concentration cascade | For formulators: 585mg+ of capsule space remains after a full 15mg MG-LZ8™ serving in a standard size 00 capsule, leaving room for co-ingredients. |
| GA/B compound (RT 32.17) — detected in MG-LZ8™, near detection limit in the comparator | Identity is provisional pending full MS/MS fragmentation. For pharmaceutical partners: a research opportunity worth characterising. |
| Five saccharides confirmed — including mannose and fucose | Mannose engages CD206 on macrophages and dendritic cells. Fucose supports selectin-ligand structures governing immune cell migration. Both absent from most supplement formats. |
Note for Oncology Practitioners
MG-LZ8™ is being developed as a 90-day protocol for post-treatment immune recalibration. The specific research hypothesis — that MG-LZ8™’s neutrophil activation capacity supports MPO-mediated clearance of carbon-based nanocarriers used in oncological drug delivery — is the subject of a proposed clinical trial at Stellenbosch University and Tygerberg Academic Hospital. Practitioners working in this space are invited to make contact directly.
Analytical documentation, sample quantities, and practitioner pricing available on request.
MG-LZ8™ is selective about the formulations and protocols it enters.
Request documentation or samples
Original laboratory reports, sample quantities, practitioner pricing, and formulator briefs available to authorised practitioners, formulators, and regulatory parties on request.
Request documentation or samples →